Omalizumab in chronic spontaneous urticaria patients nonresponsive to H1‐antihistamine treatment: Results of the phase IV open‐label SUNRISE study

British Journal of Dermatology, Volume 0, Issue ja, -Not available-.


https://ift.tt/2yNyArS